Science and Technology
December 2, 2014



Press Releases

September 23, 2013

X-Chem Achieves Early Success in Collaboration with AstraZeneca, Licenses Three Drug Discovery Programs

WALTHAM, Mass. – September 24, 2013 – X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, today announced it has achieved several milestones leading to the licensing of three drug discovery programs by AstraZeneca, in the context of a collaboration the […]

Continue Reading
Continue Reading